TNF and hepatocellular carcinoma: For instance, TNF-α -308 polymorphism is significantly associated with the risk of gastric and hepatocellular carcinomas, triple-negative breast cancer, myeloma, and lymphoma [20–24], suggesting that TNF-α may be conducive to the early diagnosis of malignancies.